ArticleCancer medicine2024

Metabolic Syndrome Is Associated With Poor Prognosis in Patients With Breast Cancer Receiving Neoadjuvant Therapy.

Youzhao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.